Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- THT's One-hour 'Fastest' Service Aims To Reduce Undiagnosed HIV In Cardiff
- New York Agency Loses Grant To Expand Services For Families Affected By HIV/AIDS
- Campaigners To SHout Loud About Sexual Health
- GPs Key To Meeting HIV Changes And Challenges, Australian
- HIV Care Providers Applaud Congress' Extension Of Ryan White Program
- Delaware HIV/AIDS Organization Forced To Close After 28 Years
- TIME Examines Voluntary Airline Tax That Aims To Fund Global Health Projects
- Houston Task Force To Target Hispanic Residents For HIV Testing
- Potential Achilles Heel On The Virus For AIDS Vaccine Discovered
- CQ Examines House Foreign Affairs Committee Outline To Overhaul U.S. Foreign Aid
Prescription AIDS Drugs
Contact Us
The Rochester Democrat and Chronicle on Thursday examined HIV/AIDS vaccine research being conducted in the area. More than 1,200 people in the Rochester area, most of whom are HIV-negative, have participated in vaccine trials at the University of Rochester Medical Center. According to the Democrat and Chronicle, the medical center runs one of the oldest vaccine research programs nationwide. Katharine Kripke of NIH, who was speaking in the area on Wednesday as part of a National HIV Vaccine Awareness Day forum, said that some people do not participate in trials because they believe they might contract HIV from experimental vaccines. She added that the experimental vaccines cannot transmit HIV.
The Democrat and Chronicle reports that researchers at the URMC vaccine program, which on Wednesday was renamed the Rochester Victory Alliance, are preparing to participate in a large-scale trial that will examine a government-developed experience vaccine among men who have sex with men. Other studies at URMC test immune responses among HIV-negative people. Michael Keefer, lead investigator for the program, said that the research has been incremental and that it might be several years before a vaccine is developed. “We’re in this for the long haul,” he said (Wang, Rochester Democrat and Chronicle, 5/7).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Related posts:
- Leading Vaccine Discovery Expert Joins The International AIDS Vaccine Initiative (IAVI) Dr. C. Richter (Rick) King, former Senior Vice President of...
- Denver Post Examines Efforts To Establish Needle-Exchange Programs In Colorado The Denver Post on Friday examined efforts to establish needle-exchange...
- HIV/AIDS Vaccine Coalition Urges Continued Funding For Research Amid Economic Crisis A recently released AIDS Vaccine Advocacy Coalition report says that...
- South Africa Launches HIV/AIDS Vaccine Trial Patient / Public: Health Professional: Article Opinions: 0 posts...
- IRIN News Examines HIV/AIDS, Other Issues Among Refugees From Myanmar IRIN News on Tuesday examined the resettlement of refugees from...
Related posts brought to you by Yet Another Related Posts Plugin.
1 Comment »
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.






[...] See original here: Rochester Democrat And Chronicle Examines Area’s HIV/AIDS Vaccine Efforts [...]
Pingback by Valuable Internet Information » Rochester Democrat And Chronicle Examines Area’s HIV/AIDS Vaccine Efforts — May 12, 2009 @ 4:16 am